Plair sells RAPID-C+, a real-time viable particle counter for monitoring pharmaceutical cleanrooms. bioMérieux is investing more than CHF 1 million in the Geneva scale-up and taking a seat on its board.
- Announced on
- Round
- Undisclosed round
- Amount
- CHF 1 M
- Location
- Geneva
- Sector
- Health & medtech
Investors
- bioMérieux
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic